Relief Therapeutics Holding AG

RLFTD · OTC
Analyze with AI
12/31/2024
6/30/2024
12/31/2023
6/30/2023
Operating Activities
Net Income-$12,562-$4,557-$41,682-$56,499
Dep. & Amort.$1,123$1,438$1,614$1,704
Deferred Tax-$2,797$560-$5,860-$7,643
Stock-Based Comp.$0$0$303$511
Change in WC$3,077-$398-$47-$944
Other Non-Cash$11,518-$130$43,605$55,669
Operating Cash Flow$359-$3,087-$7,053-$10,466
Investing Activities
PP&E Inv.-$86-$86-$77-$369
Net Acquisitions$9$0$0$0
Inv. Purchases$0$0-$5$0
Inv. Sales/Matur.$2$0$0$0
Other Inv. Act.$4,374$0$8,904$149
Investing Cash Flow$4,299-$86$8,822-$220
Financing Activities
Debt Repay.-$1$0-$16-$348
Stock Issued$0$0$85$5,009
Stock Repurch.$0$0-$7-$487
Dividends Paid$0$0$0$0
Other Fin. Act.-$245-$616-$108$4,522
Financing Cash Flow-$246-$616-$124$4,174
Forex Effect$0$0$119$67
Net Chg. in Cash$0-$3,828$1,764-$6,445
Supplemental Information
Beg. Cash$10,728$14,556$12,792$19,237
End Cash$15,080$10,728$14,556$12,792
Free Cash Flow$345-$3,173-$7,130-$10,835
Relief Therapeutics Holding AG (RLFTD) Financial Statements & Key Stats | AlphaPilot